AAAAAA
Results:
1-12
|
Results: 12
Authors:
Muders, F
Palkovits, M
Bahner, U
Kirst, I
Elsner, D
Jandeleit-Dahm, K
Citation: F. Muders et al., Central inhibition of AT(1) receptors by eprosartan - In vitro autoradiography in the brain, PHARMAC RES, 43(3), 2001, pp. 251-255
Authors:
Kosch, M
Bahner, U
Bettger, H
Matzkies, F
Teschner, M
Schaefer, RM
Citation: M. Kosch et al., A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer (R)) vs iron gluconate (Ferrlecit (R)) in haemodialysispatients treated with rHuEpo, NEPH DIAL T, 16(6), 2001, pp. 1239-1244
Authors:
Hu, K
Bahner, U
Gaudron, P
Palkovits, M
Ring, M
Fehle, A
Kruse, B
Ertl, G
Citation: K. Hu et al., Chronic effects of ACE-inhibition (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei ofrats with experimental myocardial infarction, BAS R CARD, 96(3), 2001, pp. 258-266
Authors:
Stopper, H
Boullay, F
Heidland, A
Vienken, J
Bahner, U
Citation: H. Stopper et al., Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients, AM J KIDNEY, 38(2), 2001, pp. 296-301
Authors:
Schaefer, RM
Barenbrock, M
Teschner, M
Bahner, U
Citation: Rm. Schaefer et al., Renal replacement therapy for acute renal failure in the ICU, MED KLIN, 95(5), 2000, pp. 273-278
Authors:
Gerdemann, A
Lemke, HD
Nothdurft, A
Heidland, A
Munch, G
Bahner, U
Schinzel, R
Citation: A. Gerdemann et al., Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis, CLIN NEPHR, 54(4), 2000, pp. 276-283
Authors:
Schaefer, RM
Bahner, U
Citation: Rm. Schaefer et U. Bahner, Iron metabolism in rhEPO-treated hemodialysis patients, CLIN NEPHR, 53, 2000, pp. S65-S68
Authors:
Bahner, U
Sebekova, K
Heidland, A
Citation: U. Bahner et al., Chronic metabolic acidosis - are the clinical consequences underestimated?, NIEREN HOCH, 29(2), 2000, pp. 71-80
Authors:
Heidland, A
Bahner, U
Vamvakas, S
Citation: A. Heidland et al., Incidence and spectrum of dialysis-associated cancer in three continents, AM J KIDNEY, 35(2), 2000, pp. 347-351
Authors:
Stopper, H
Meysen, T
Bockenforde, A
Bahner, U
Heidland, A
Vamvakas, S
Citation: H. Stopper et al., Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy, AM J KIDNEY, 34(3), 1999, pp. 433-437
Authors:
Matzkies, FK
Bahner, U
Teschner, M
Hohage, H
Heidland, A
Schaefer, RM
Citation: Fk. Matzkies et al., Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patientswith nephrotic syndrome, AM J NEPHR, 19(4), 1999, pp. 492-494
Authors:
Bahner, U
Heidland, A
Citation: U. Bahner et A. Heidland, Acetylsalicyclic acid in renal insufficiency, INTERNIST, 39(11), 1998, pp. 1186-1186
Risultati:
1-12
|